You’ve got an inbox full of unread ‘must-read’ Pharma and biotech articles, right?

Or an empty diary where company-expensed lunches and conferences once where?

And you just can’t seem to find the time to get the full lowdown on the latest drug development trends…

Well, listen up, because we have a podcast for you

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines (just think of your favourite podcast and that’s what we’re doing, but with drug supply chain shortages instead of unsolved crimes and life science leaders instead of sports stars).

As the name suggests, our podcast is all about the ins and outs of the drug development industry – from early phase discovery to commercial supply – with a particular focus on interviewing those working in the pharma and biotech contract services space.

Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

Keep updated

Latest episodes

View all episodes
  • Peter Bigelow

    xCell Strategic Consulting

    Poacher turned gamekeeper, turned hybrid

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Bigelow President at xCell Strategic Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: The transition from being on the big pharma sponsor side at Pfizer to being head

    Read more
  • Steve Ferguson

    Medix Biochemica

    The humble leader

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steve Ferguson, Chief Executive Officer at Medix Biochemica. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steve, covering: The positive and negative impact of Covid-19 on the diagnostic sector. And the need

    Read more
  • Archie Lovatt

    SGS

    The understated, elite vaccine scientist

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Archie Lovatt Life Sciences Biosafety Scientific Director at SGS. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Archie, covering: Being motivated by saving lives and seeing your contribution make a real

    Read more
  • Jeff Dill

    Vynamic

    Creating a healthy culture

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:·     How to create, document, grow and internationally scale an incredible business culture. The shift towards greater industry collaboration as

    Read more

Keep updated